Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 4, 2010, Pages 568-571

  Kimura, Michitaka ^a   Tojo, Takashi ^a   Naito, Hiroshi ^a   Nagata, Yoko ^a   Kawai, Norikazu ^a   Taniguchi, Shigeki ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dissemination; Intrathoracic chemotherapy; Intrathoracic thermotherapy; Lung cancer; Malignant pleural effusion

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEFITINIB; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PACLITAXEL; SODIUM CHLORIDE; TS 1; UFT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MALE; OPERATION DURATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; THORAX SURGERY; TREATMENT OUTCOME; TUMOR VOLUME; VIDEO ASSISTED THORACOSCOPIC SURGERY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE CARE; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLEURAL EFFUSION, MALIGNANT; PNEUMONECTOMY; RECURRENCE; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950632875     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.225110     Document Type: Article

References (9)

1. Ichinose Y, Tsuchiya R, Koike T, Kuwahara O, Nakagawa K, Yamato Y, Kobayashi K, Watanabe Y, Kase M, Yokoi K, and the Japan Oncology Group. Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer 2001;32:55-60.
2. Shigemura N, Akashi A, Ohta M, Matsuda H. Combined surgery of intrapleural perfusion hyperthermic chemotherapy and panpleuropneu-monectomy for lung cancer with advanced pleural spread: a pilot study. Interact CardioVasc Thorac Surg 2003;2:671-675.
3. Kodama K, Doi O, Higashiyama M, Yokouchi H, Tatsuta M. Long-term results of postoperative intrathoracic chemo-thermotherapy for lung cancer with pleural dissemination. Cancer 1993;72:426-431.
4. Matsuzaki Y, Shibata K, Yoshioka M, Inoue M, Sekiya R, Onitsuka T, Iwamoto I, Koga Y. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion. Ann Thorac Surg 1995;59:127-131.
5. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006;29:829-838.
6. Fujita A, Takabatake H, Tagaki S, Sekine K. Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer. Chest 2001;119:340-343.
7. Vertrees RA, Zwischenberger JB, Boor PJ, Pencil SD. Oncogenic ras results in increased cell kill due to defective thermoprotection in lung cancer cells. Ann Thorac Surg 2000;69:1675-1680.
8. Zwischenberger JB, Vertrees RA, Bedell EA, McQuitty CK, Chernin JM, Woodson LC. Percutaneous venovenous perfusion-induced systemic hyperthermia for lung cancer: a phase I safety study. Ann Thorac Surg 2004;77:1916-1925.
9. Zwischenberger JB, Vertrees RA, Woodson LC, Bedell EA, Alpard SK, McQuitty CK, Chernin JM. Percutaneous venovenous perfusion-induced systemic hyperthermia for advanced non-small cell lung cancer: initial clinical experience. Ann Thorac Surg 2001;72:234-242.